Section
The Week
Weekly roundup of what mattered and why
The WeekFiercePharma ↗
Insulet and Calm are integrating mental health care into diabetes treatment with a series of mindfulness, medi…
The WeekFierceBiotech ↗
Spero pivots to I&I with $1.1B deal for Innovent antibody, sells slice of Utebzi royalties for $105M
Spero Therapeutics is pivoting to immune and inflammation indications through a license agreement for a CD40L …
The WeekBriefing
Jemperli met its main goal in a phase 2 trial for certain rectal cancers, and GSK now plans to seek U.S. appro…
The WeekSTAT News ↗
A former FDA toxicologist has accused the agency of authorizing Zyn nicotine pouches without fully reviewing t…
The WeekPharmaceutical Technology ↗
Novartis has entered a collaboration with Chai Discovery to advance the use of AI in the identification of the…
The WeekBioPharma Dive ↗
The new study results could make Abbott, which has an agreement with Freenome to market the blood-based test, …
Page 1
Older →
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.